Soluble CD44 isoform variant-5 (sCD44v5) : a new serum marker in rheumatoid arthritis?
Haberhauer, G.; Kittl, E.M.
Journal of Rheumatology 25(7): 1442-1444
1998
ISSN/ISBN: 0315-162X PMID: 9676786 Document Number: 493328
Document emailed within 1 workday
Related Documents
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162Huizinga, T.W.J.; Ioan-Facsinay, A. 2003: Soluble FcgammaRIIIa as a marker for rheumatoid arthritis: the use of genetics in selected populations to study pathogenetic pathways Journal of Rheumatology 30(9): 1904-1906
Coaccioli, S.; Pinoca, F.; Giuliani, M.; Landucci, P.; Sabatini, C.; Puxeddu, A. 2007: Definition of adult-onset rheumatoid arthritis from elderly-onset rheumatoid arthritis by studying T-lymphocyte subpopulations, their soluble receptors and soluble receptor of interleukin-2 La Clinica Terapeutica 158(4): 303-306
Zhao, S.; Guo, Y-Ying.; Ding, N.; Yang, L-Li.; Zhang, N. 2011: Changes in serum levels of soluble osteoclast-associated receptor in human rheumatoid arthritis Chinese Medical Journal 124(19): 3058-3060
Boiardi, L.; Macchioni, P.; Salvarani, C.; Rossi, F.; Casadei-Maldini, M.; Mancini, R.; Beltrandi, E.; Portioli, I. 1994: Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment Clinical and Experimental Rheumatology 12(4): 357-362
Grieble, H.; Bach, G.; Anderson, T.; Zschocke, R. 1971: Standardization of the latex fixation test for the demonstration of the rheumatoid factor. 3. Nature of the rheumatoid factor in normal serum, in serum of patients with rheumatoid arthritis, and in serum of the aged Acta Biologica et Medica Germanica 26(1): 185-191
Kuuliala, A.; Leirisalo-Repo, M.; Möttönen, T.; Hannonen, P.; Nissilä, M.; Kautiainen, H.; Korpela, M.; Julkunen, H.; Hakola, M.; Repo, H. 2005: Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug Clinical and Experimental Rheumatology 23(2): 243-246
Sundrarjun, T.; Komindr, S.; Archararit, N.; Dahlan, W.; Puchaiwatananon, O.; Angthararak, S.; Udomsuppayakul, U.; Chuncharunee, S. 2004: Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis Journal of International Medical Research 32(5): 443-454
Wolf, R.E.; Brelsford, W.G.; Hall, V.C.; Adams, S.B. 1992: Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis Journal of Rheumatology 19(4): 524-528
Krel', A.A.; Semenova, O.I.; Kanevskaia, M.Z.; Shekhter, A.B. 1994: Drug-induced remission in the severe progressive variant of rheumatoid arthritis Terapevticheskii Arkhiv 66(1): 24-29
Ivanov, O.F.; Shakhbazian, I.E. 1983: Age-related characteristics of the pauciarticular variant of an articular form of juvenile rheumatoid arthritis Pediatriia 11: 36-38
Symons, J.A.; Wood, N.C.; Di Giovine, F.S.; Duff, G.W. 1988: Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition Journal of Immunology 141(8): 2612-2618
Nishimura, Y.; Sasatsuki, T. 1988: HLA as a marker gene in the diagnosis and treatment of chronic rheumatoid arthritis Ryumachi 28(6): 463-466
Basu, P.S.; Majhi, R.; Ghosal, S.; Batabyal, S.K. 2011: Peptidyl-Arginine Deiminase: An Additional Marker of Rheumatoid Arthritis Clinical Laboratory 57(11-12): 1021-1025
Abu Al Fadl, E.M.; Fattouh, M.; Allam, A.A. 2013: High IL-23 level is a marker of disease activity in rheumatoid arthritis Egyptian Journal of Immunology 20(2): 85-92
Medvedev, A.N.; Korshunov, N.I.; Nasonov, E.L.; Baranov, A.A.; Shilkina, B.N. 1997: The effect of cyclosporin a (Sandimmun) on the level of soluble interleukin-2 receptors in rheumatoid arthritis Terapevticheskii Arkhiv 69(8): 19-21
Hayem, G.; Chazerain, P.; Combe, B.; Elias, A.; Haim, T.; Nicaise, P.; Benali, K.; Eliaou, J.F.; Kahn, M.F.; Sany, J.; Meyer, O. 1999: Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis Journal of Rheumatology 26(1): 7-13
Syed Mohamed Suhail, S.M.; Nur Atiqah, I.; Nur Salimi Zakirah, Z.A.; Lailatul Syazwani, Z.; Batis, W.W.; Md Monoto, E.M.; Abdul Wahab, A.; Mohd Shahrir, M.S. 2019: Diagnostic performance of anti-RA33 antibody as a serological marker for rheumatoid arthritis Malaysian Journal of Pathology 41(3): 259-265
Chrobák, L.; Podzimek, K.; Plísková, L.; Kerekes, Z.; Zák, P.; Voglová, J.; Spacek, J.; Palicka, V. 1996: Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia Neoplasma 43(5): 321-325
Goodwin, J.S.; Ceuppens, J.L.; Rodriguez, M.A. 1983: Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels JAMA 250(18): 2485-2488